According to the U.S. health agency, Glenmark Pharmaceuticals is recalling over 15 lakh bottles of a generic drug used to ...

Glenmark Pharmaceuticals Inc, USA, an arm of the Mumbai-based Glenmark Pharmaceuticals, is recalling around 14.76 lakh ...

The recall affects around 14.76 lakh bottles of Atomoxetine Capsules in various strengths, produced by Glenmark ...

Glenmark Pharmaceuticals recalls 14.76 lakh bottles of Atomoxetine Capsules in the US due to impurity concerns.

Glenmark Pharmaceuticals Inc, USA, a subsidiary of the Mumbai-based drug maker, is recalling around 14.76 lakh bottles of ...

ADHD is a neurodevelopmental disorder that affects a person's ability to focus, control impulses, and regulate their activity ...

Glenmark Pharmaceuticals is recalling 15 lakh bottles of Atomoxetine Capsules in the US due to an N-Nitroso Atomoxetine ...

ADHD medications reduce mortality risk by 19% while improving cognitive function, yet 87% of adults with symptoms never seek ...

As national pressure mounts for some medications for the mind, the FDA reveals a question that arose for a major pharmaceutical manufacturer.